# Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ≥50%: real-world data

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/pembrolizumab-as-a-monotherapy-or-in-combination-with-platinum-based/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Elizabeth Dudnik,Mor Moskovitz,Yakir Rottenberg,Anastasiya Lobachov,Rinat Mandelboim,Tzippy Shochat,Damien Urban,Mira Wollner,Hovav Nechushtan,Ofer Rotem,Alona Zer,Sameh Daher,Jair Bar,On behalf of the Israel Lung Cancer Group |
| Citations | 71 |
| DOI | 10.1080/2162402x.2020.1865653 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2020.1865653?needAccess=true |
| OpenAlex ID | https://openalex.org/W3126407524 |
| PMID | 33552685 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Damien Urban](https://scholariq.org/researchers/damien-urban/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.